Skip to main content
Erschienen in: Annals of Surgical Oncology 9/2017

06.07.2017 | Endocrine Tumors

Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma

verfasst von: Seo Ki Kim, MD, Ah-Young Kwon, MD, Kyorim Back, MD, Inhye Park, MD, Nayoon Hur, MD, Jun Ho Lee, MD, Jun-Ho Choe, MD, PhD, Jung-Han Kim, MD, PhD, Young Lyun Oh, MD, PhD, Jee Soo Kim, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Compared with conventional papillary thyroid carcinoma (PTC), follicular variant of PTC (FV-PTC) shows less aggressive behavior and better prognosis. Nonetheless, regional lymph node (LN) metastasis was found in 22.8% of FV-PTC patients. Because LN metastasis is a proven predictor of recurrence in PTC, it is important to assess LN metastasis in FV-PTC patients.

Methods

We retrospectively reviewed 134 FV-PTC patients who underwent thyroidectomy with neck dissection.

Results

Central LN metastasis (CLNM) and lateral LN metastasis (LLNM) were found in 50 (37.3%) and 16 (11.9%) patients, respectively. In the multivariate analysis for CLNM, male sex (adjusted OR 4.735, p = 0.001), nonencapsulated form (adjusted OR 2.863, p = 0.022), and tumor size >1.0 cm (adjusted OR 3.157, p = 0.008) were independent predictors of high prevalence of CLNM in FV-PTC patients. In the multivariate analysis for LLNM, microscopic extrathyroidal extension (ETE) (adjusted OR 3.939, p = 0.041) and CLNM (adjusted OR 13.340, p = 0.001) were independent predictors of high prevalence of LLNM in FV-PTC patients.

Conclusions

Meticulous perioperative evaluation and prophylactic central neck dissection may be beneficial for FV-PTC patients with male sex, nonencapsulated form, and tumor size >1.0 cm. Moreover, cautious perioperative evaluation of lateral neck LN may be mandatory for FV-PTC patients with microscopic ETE and CLNM.
Literatur
1.
Zurück zum Zitat Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMed Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.CrossRefPubMed
2.
Zurück zum Zitat Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30-year clinicopathological review of the histological variants. Endocr Pathol. 2005;16:323–30.CrossRefPubMed Lam AK, Lo CY, Lam KS. Papillary carcinoma of thyroid: A 30-year clinicopathological review of the histological variants. Endocr Pathol. 2005;16:323–30.CrossRefPubMed
3.
Zurück zum Zitat Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003;97:1181–5.CrossRefPubMed Zidan J, Karen D, Stein M, Rosenblatt E, Basher W, Kuten A. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival. Cancer. 2003;97:1181–5.CrossRefPubMed
4.
Zurück zum Zitat Crile G, Jr., Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg. 1953;138:33–8.CrossRefPubMedPubMedCentral Crile G, Jr., Hazard JB. Relationship of the age of the patient to the natural history and prognosis of carcinoma of the thyroid. Ann Surg. 1953;138:33–8.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Rosai J, Carcangiu M, Delellis R, Rosai J, Sobin L. Follicular carcinomas. Papillary carcinomas. Rosai J, Sobin LH. Tumors of the thyroid gland. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology. 1992:49–121. Rosai J, Carcangiu M, Delellis R, Rosai J, Sobin L. Follicular carcinomas. Papillary carcinomas. Rosai J, Sobin LH. Tumors of the thyroid gland. Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology. 1992:49–121.
7.
Zurück zum Zitat Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30:752–8.CrossRefPubMed Lang BH, Lo CY, Chan WF, Lam AK, Wan KY. Classical and follicular variant of papillary thyroid carcinoma: a comparative study on clinicopathologic features and long-term outcome. World J Surg. 2006;30:752–8.CrossRefPubMed
8.
Zurück zum Zitat Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid. 2013;23:1263–8.CrossRefPubMedPubMedCentral Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid. 2013;23:1263–8.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Shi X, Liu R, Basolo F, et al. Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J Clin Endocrinol Metab. 2016;101:264–74.CrossRefPubMed Shi X, Liu R, Basolo F, et al. Differential clinicopathological risk and prognosis of major papillary thyroid cancer variants. J Clin Endocrinol Metab. 2016;101:264–74.CrossRefPubMed
10.
Zurück zum Zitat Yang J, Gong Y, Yan S, et al. Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis. Mol Clin Oncol. 2015;3:753–64.PubMedPubMedCentral Yang J, Gong Y, Yan S, et al. Comparison of the clinicopathological behavior of the follicular variant of papillary thyroid carcinoma and classical papillary thyroid carcinoma: A systematic review and meta-analysis. Mol Clin Oncol. 2015;3:753–64.PubMedPubMedCentral
11.
Zurück zum Zitat Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7; discussion 7–8.CrossRefPubMed Hay ID, Hutchinson ME, Gonzalez-Losada T, et al. Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period. Surgery. 2008;144:980–7; discussion 7–8.CrossRefPubMed
12.
Zurück zum Zitat Kesmodel SB, Terhune KP, Canter RJ, et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery. 2003;134:1005–12; discussion 12.CrossRefPubMed Kesmodel SB, Terhune KP, Canter RJ, et al. The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery. 2003;134:1005–12; discussion 12.CrossRefPubMed
13.
Zurück zum Zitat Blanchard C, Brient C, Volteau C, et al. Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br J Surg. 2013;100:1312–7.CrossRefPubMed Blanchard C, Brient C, Volteau C, et al. Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma. Br J Surg. 2013;100:1312–7.CrossRefPubMed
14.
Zurück zum Zitat Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023–9.CrossRefPubMed Nikiforov YE, Seethala RR, Tallini G, et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol. 2016;2:1023–9.CrossRefPubMed
15.
Zurück zum Zitat American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214.
16.
Zurück zum Zitat Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.
17.
Zurück zum Zitat Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:273–9.CrossRefPubMed Vivero M, Kraft S, Barletta JA. Risk stratification of follicular variant of papillary thyroid carcinoma. Thyroid. 2013;23:273–9.CrossRefPubMed
18.
Zurück zum Zitat Kim SK, Woo JW, Lee JH, et al. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Surgery. 2015. 10.1016/j.surg.2015.05.016 Kim SK, Woo JW, Lee JH, et al. Role of BRAF V600E mutation as an indicator of the extent of thyroidectomy and lymph node dissection in conventional papillary thyroid carcinoma. Surgery. 2015. 10.​1016/​j.​surg.​2015.​05.​016
19.
Zurück zum Zitat Kim SK, Woo JW, Lee JH, et al. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23:27–34.CrossRefPubMed Kim SK, Woo JW, Lee JH, et al. Chronic lymphocytic thyroiditis and BRAF V600E in papillary thyroid carcinoma. Endocr Relat Cancer. 2016;23:27–34.CrossRefPubMed
20.
Zurück zum Zitat Chai YJ, Kim SJ, Kim SC, et al. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography. Clin Endocrinol (Oxf). 2014;81:432–9.CrossRef Chai YJ, Kim SJ, Kim SC, et al. BRAF mutation in follicular variant of papillary thyroid carcinoma is associated with unfavourable clinicopathological characteristics and malignant features on ultrasonography. Clin Endocrinol (Oxf). 2014;81:432–9.CrossRef
21.
Zurück zum Zitat Finnerty BM, Kleiman DA, Scognamiglio T, et al. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol. 2015;22:1200–6.CrossRefPubMed Finnerty BM, Kleiman DA, Scognamiglio T, et al. Navigating the management of follicular variant papillary thyroid carcinoma subtypes: a classic PTC comparison. Ann Surg Oncol. 2015;22:1200–6.CrossRefPubMed
22.
Zurück zum Zitat Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107:1255–64.CrossRefPubMed Liu J, Singh B, Tallini G, et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006;107:1255–64.CrossRefPubMed
23.
Zurück zum Zitat Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Arch Otolaryngol Head Neck Surg. 2012;138:227–33.CrossRefPubMedPubMedCentral Gupta S, Ajise O, Dultz L, et al. Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities. Arch Otolaryngol Head Neck Surg. 2012;138:227–33.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Kwak JY, Kim EK, Kim MJ, et al. Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann Surg Oncol. 2009;16:1348–55.CrossRefPubMed Kwak JY, Kim EK, Kim MJ, et al. Papillary microcarcinoma of the thyroid: predicting factors of lateral neck node metastasis. Ann Surg Oncol. 2009;16:1348–55.CrossRefPubMed
25.
Zurück zum Zitat Park JH, Lee YS, Kim BW, Chang HS, Park CS. Skip lateral neck node metastases in papillary thyroid carcinoma. World J Surg. 2012;36:743–7.CrossRefPubMed Park JH, Lee YS, Kim BW, Chang HS, Park CS. Skip lateral neck node metastases in papillary thyroid carcinoma. World J Surg. 2012;36:743–7.CrossRefPubMed
26.
Zurück zum Zitat Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139:43–5.CrossRefPubMed Machens A, Holzhausen HJ, Dralle H. Skip metastases in thyroid cancer leaping the central lymph node compartment. Arch Surg. 2004;139:43–5.CrossRefPubMed
27.
Zurück zum Zitat Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.CrossRefPubMed Lloyd RV, Erickson LA, Casey MB, et al. Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol. 2004;28:1336–40.CrossRefPubMed
Metadaten
Titel
Predictive Factors of Lymph Node Metastasis in Follicular Variant of Papillary Thyroid Carcinoma
verfasst von
Seo Ki Kim, MD
Ah-Young Kwon, MD
Kyorim Back, MD
Inhye Park, MD
Nayoon Hur, MD
Jun Ho Lee, MD
Jun-Ho Choe, MD, PhD
Jung-Han Kim, MD, PhD
Young Lyun Oh, MD, PhD
Jee Soo Kim, MD, PhD
Publikationsdatum
06.07.2017
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 9/2017
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-5912-5

Weitere Artikel der Ausgabe 9/2017

Annals of Surgical Oncology 9/2017 Zur Ausgabe

Health Services Research and Global Oncology

Global Forum of Cancer Surgeons: Declaration of Intent

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.